Logo image of NVJP.DE

UMICORE (NVJP.DE) Stock Fundamental Analysis

FRA:NVJP - Deutsche Boerse Ag - BE0974320526 - Common Stock - Currency: EUR

9.855  +0.27 (+2.76%)

Fundamental Rating

4

Taking everything into account, NVJP scores 4 out of 10 in our fundamental rating. NVJP was compared to 60 industry peers in the Chemicals industry. While NVJP is still in line with the averages on profitability rating, there are concerns on its financial health. NVJP has a valuation in line with the averages, but it does not seem to be growing. Finally NVJP also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year NVJP was profitable.
In the past year NVJP had a positive cash flow from operations.
NVJP had positive earnings in each of the past 5 years.
NVJP had a positive operating cash flow in each of the past 5 years.
NVJP.DE Yearly Net Income VS EBIT VS OCF VS FCFNVJP.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M 1B

1.2 Ratios

The Return On Assets of NVJP (3.86%) is better than 66.67% of its industry peers.
NVJP has a Return On Equity of 10.52%. This is in the better half of the industry: NVJP outperforms 75.44% of its industry peers.
The Return On Invested Capital of NVJP (7.37%) is better than 77.19% of its industry peers.
NVJP had an Average Return On Invested Capital over the past 3 years of 10.16%. This is above the industry average of 6.58%.
Industry RankSector Rank
ROA 3.86%
ROE 10.52%
ROIC 7.37%
ROA(3y)5.48%
ROA(5y)4.42%
ROE(3y)15.54%
ROE(5y)12.57%
ROIC(3y)10.16%
ROIC(5y)8.82%
NVJP.DE Yearly ROA, ROE, ROICNVJP.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 2.11%, NVJP is in line with its industry, outperforming 54.39% of the companies in the same industry.
NVJP's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 3.23%, NVJP is in line with its industry, outperforming 54.39% of the companies in the same industry.
NVJP's Operating Margin has been stable in the last couple of years.
Looking at the Gross Margin, with a value of 8.24%, NVJP is doing worse than 84.21% of the companies in the same industry.
In the last couple of years the Gross Margin of NVJP has remained more or less at the same level.
Industry RankSector Rank
OM 3.23%
PM (TTM) 2.11%
GM 8.24%
OM growth 3Y19.34%
OM growth 5Y-0.8%
PM growth 3Y49.37%
PM growth 5Y-1.82%
GM growth 3Y13.74%
GM growth 5Y-1.13%
NVJP.DE Yearly Profit, Operating, Gross MarginsNVJP.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2 4 6 8

More info and screens

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), NVJP is creating some value.
The number of shares outstanding for NVJP remains at a similar level compared to 1 year ago.
NVJP has less shares outstanding than it did 5 years ago.
The debt/assets ratio for NVJP is higher compared to a year ago.
NVJP.DE Yearly Shares OutstandingNVJP.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
NVJP.DE Yearly Total Debt VS Total AssetsNVJP.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B

2.2 Solvency

An Altman-Z score of 2.91 indicates that NVJP is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.91, NVJP is doing good in the industry, outperforming 73.68% of the companies in the same industry.
The Debt to FCF ratio of NVJP is 17.40, which is on the high side as it means it would take NVJP, 17.40 years of fcf income to pay off all of its debts.
NVJP has a Debt to FCF ratio of 17.40. This is comparable to the rest of the industry: NVJP outperforms 49.12% of its industry peers.
A Debt/Equity ratio of 0.55 indicates that NVJP is somewhat dependend on debt financing.
NVJP has a Debt to Equity ratio of 0.55. This is comparable to the rest of the industry: NVJP outperforms 40.35% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 17.4
Altman-Z 2.91
ROIC/WACC1.29
WACC5.7%
NVJP.DE Yearly LT Debt VS Equity VS FCFNVJP.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B

2.3 Liquidity

NVJP has a Current Ratio of 1.62. This is a normal value and indicates that NVJP is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of NVJP (1.62) is worse than 64.91% of its industry peers.
NVJP has a Quick Ratio of 1.62. This is a bad value and indicates that NVJP is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of NVJP (0.82) is worse than 82.46% of its industry peers.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 0.82
NVJP.DE Yearly Current Assets VS Current LiabilitesNVJP.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

More info and screens

1

3. Growth

3.1 Past

NVJP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -34.29%.
Measured over the past 5 years, NVJP shows a small growth in Earnings Per Share. The EPS has been growing by 4.10% on average per year.
NVJP shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -30.40%.
The Revenue has been growing slightly by 5.90% on average over the past years.
EPS 1Y (TTM)-34.29%
EPS 3Y11.55%
EPS 5Y4.1%
EPS Q2Q%-49.48%
Revenue 1Y (TTM)-30.4%
Revenue growth 3Y-4.1%
Revenue growth 5Y5.9%
Sales Q2Q%-14.1%

3.2 Future

The Earnings Per Share is expected to decrease by -2.66% on average over the next years.
NVJP is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.69% yearly.
EPS Next Y-40.91%
EPS Next 2Y-25.87%
EPS Next 3Y-15.82%
EPS Next 5Y-2.66%
Revenue Next Year-11.63%
Revenue Next 2Y-5.51%
Revenue Next 3Y-2.7%
Revenue Next 5Y-1.69%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
NVJP.DE Yearly Revenue VS EstimatesNVJP.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B 25B
NVJP.DE Yearly EPS VS EstimatesNVJP.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0.5 1 1.5 2 2.5

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

NVJP is valuated cheaply with a Price/Earnings ratio of 7.14.
94.74% of the companies in the same industry are more expensive than NVJP, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 28.47, NVJP is valued rather cheaply.
The Price/Forward Earnings ratio is 9.64, which indicates a very decent valuation of NVJP.
Based on the Price/Forward Earnings ratio, NVJP is valued cheaper than 92.98% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 92.74, NVJP is valued rather cheaply.
Industry RankSector Rank
PE 7.14
Fwd PE 9.64
NVJP.DE Price Earnings VS Forward Price EarningsNVJP.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

91.23% of the companies in the same industry are more expensive than NVJP, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, NVJP is valued a bit cheaper than 75.44% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.38
EV/EBITDA 4.12
NVJP.DE Per share dataNVJP.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

A cheap valuation may be justified as NVJP's earnings are expected to decrease with -15.82% in the coming years.
PEG (NY)N/A
PEG (5Y)1.74
EPS Next 2Y-25.87%
EPS Next 3Y-15.82%

More info and screens

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.52%, NVJP is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.94, NVJP pays a better dividend. On top of this NVJP pays more dividend than 85.96% of the companies listed in the same industry.
NVJP's Dividend Yield is rather good when compared to the S&P500 average which is at 2.28.
Industry RankSector Rank
Dividend Yield 5.52%

5.2 History

The dividend of NVJP has a limited annual growth rate of 1.00%.
Dividend Growth(5Y)1%
Div Incr Years0
Div Non Decr Years4
NVJP.DE Yearly Dividends per shareNVJP.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 0.2 0.4 0.6

5.3 Sustainability

NVJP pays out 49.94% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP49.94%
EPS Next 2Y-25.87%
EPS Next 3Y-15.82%
NVJP.DE Yearly Income VS Free CF VS DividendNVJP.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M -400M 600M 800M
NVJP.DE Dividend Payout.NVJP.DE Dividend Payout, showing the Payout Ratio.NVJP.DE Dividend Payout.PayoutRetained Earnings

More info and screens

UMICORE

FRA:NVJP (2/4/2025, 7:00:00 PM)

9.855

+0.27 (+2.76%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A N/A
Earnings (Next)02-14 2025-02-14/amc
Inst Owners47.53%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.43B
Analysts54.4
Price Target13.85 (40.54%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.52%
Yearly Dividend0.8
Dividend Growth(5Y)1%
DP49.94%
Div Incr Years0
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.45%
PT rev (3m)-9.02%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.65%
EPS NY rev (3m)-0.65%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.57%
Revenue NY rev (3m)0.57%
Valuation
Industry RankSector Rank
PE 7.14
Fwd PE 9.64
P/S 0.13
P/FCF 15.38
P/OCF 2.33
P/B 0.66
P/tB 0.74
EV/EBITDA 4.12
EPS(TTM)1.38
EY14%
EPS(NY)1.02
Fwd EY10.37%
FCF(TTM)0.64
FCFY6.5%
OCF(TTM)4.23
OCFY42.94%
SpS74.13
BVpS14.86
TBVpS13.31
PEG (NY)N/A
PEG (5Y)1.74
Profitability
Industry RankSector Rank
ROA 3.86%
ROE 10.52%
ROCE 9.27%
ROIC 7.37%
ROICexc 9.66%
ROICexgc 10.49%
OM 3.23%
PM (TTM) 2.11%
GM 8.24%
FCFM 0.86%
ROA(3y)5.48%
ROA(5y)4.42%
ROE(3y)15.54%
ROE(5y)12.57%
ROIC(3y)10.16%
ROIC(5y)8.82%
ROICexc(3y)14.53%
ROICexc(5y)11.79%
ROICexgc(3y)15.79%
ROICexgc(5y)12.81%
ROCE(3y)13.89%
ROCE(5y)12.23%
ROICexcg growth 3Y19.44%
ROICexcg growth 5Y4.25%
ROICexc growth 3Y18.72%
ROICexc growth 5Y4.1%
OM growth 3Y19.34%
OM growth 5Y-0.8%
PM growth 3Y49.37%
PM growth 5Y-1.82%
GM growth 3Y13.74%
GM growth 5Y-1.13%
F-Score5
Asset Turnover1.83
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 17.4
Debt/EBITDA 2.27
Cap/Depr 296.37%
Cap/Sales 4.84%
Interest Coverage 6.98
Cash Conversion 117.26%
Profit Quality 41.01%
Current Ratio 1.62
Quick Ratio 0.82
Altman-Z 2.91
F-Score5
WACC5.7%
ROIC/WACC1.29
Cap/Depr(3y)205.73%
Cap/Depr(5y)204.13%
Cap/Sales(3y)2.84%
Cap/Sales(5y)2.79%
Profit Quality(3y)67.38%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-34.29%
EPS 3Y11.55%
EPS 5Y4.1%
EPS Q2Q%-49.48%
EPS Next Y-40.91%
EPS Next 2Y-25.87%
EPS Next 3Y-15.82%
EPS Next 5Y-2.66%
Revenue 1Y (TTM)-30.4%
Revenue growth 3Y-4.1%
Revenue growth 5Y5.9%
Sales Q2Q%-14.1%
Revenue Next Year-11.63%
Revenue Next 2Y-5.51%
Revenue Next 3Y-2.7%
Revenue Next 5Y-1.69%
EBIT growth 1Y-27.85%
EBIT growth 3Y14.45%
EBIT growth 5Y5.05%
EBIT Next Year11.59%
EBIT Next 3Y6.72%
EBIT Next 5Y4.6%
FCF growth 1Y10.53%
FCF growth 3Y19.39%
FCF growth 5YN/A
OCF growth 1Y64.41%
OCF growth 3Y25.44%
OCF growth 5YN/A